Not known Details About Multiple system atrophy
. A section II randomized managed research in people with MSA assessing efficacy of oral sirolimus on slowing disease progression was just lately prematurely terminated because Conference the futility standards (NCT03589976). These mutations cause decreased manufacture of Coenzyme Q10 (CoQ10), which is an electron carrier during the mitochondrial